What's New

Talazoparib (Talzenna™)

Talazoparib (Talzenna™) is a PARP inhibitor used in the treatment of some types of breast cancer. 

Cemiplimab-rwlc (Libtayo®)

Cemiplimab-rwlc (Libtayo®) is a monoclonal antibody used in the treatment of some cases of squamous cell cancer of the skin. 

Dacomitinib (Vizimpro®)

Dacomitinib is a tyrosine kinase inhibitor used in the treatment of non-small cell lung cancers with certain EGFR mutations.

Duvelisib (Copiktra ™)

Duvelisib (Copiktra ™) is a kinase inhibitor used in the treatment of some cases of CLL, small lymphocytic lymphoma and follicular lymphoma. 


OncoLink's Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

Why tenacity matters in the face of cancer
by Marlys Johnson
Oct 22, 2018

Medicare Part D-What You Need to Know for Open Enrollment
by Christina Bach, MSW, LCSW, OSW-C
Oct 18, 2018

View all Blogs

Cancer Awareness

Breast Cancer Awareness Month

October is breast cancer awareness month- in case you haven't yet noticed the sea of pink. We would like to not only support those fighting and surviving breast cancer, but we would like to encourage others to learn more about risk and prevention. Risk is complicated, but incorporating a healthy diet, exercise and maintaining a healthy weight, can reduce your risk of developing breast cancer OR having a recurrence. You can also learn more about cancer screening for women in general.

Need Cancer Patient Education Tools?

Our award winning cancer education content is now available for licensing and syndication.

I Wish U Knew!

I Wish U Knew is a video series featuring oncology professionals and survivors discussing what they wish patients and the public knew about cancer.